In this review, we summarize the structural and biological features of IgM, outline recent advances in IgM-based therapeutic antibodies for solid tumor therapy, discuss major challenges such as short half-life, limited tumor penetration, and manufacturing complexity, and offer perspectives on future directions. Here, CD40LG is linked to neoplasm.